January 10, 2021
*I have listed in white, below, my academic credentials in immunology & molecular biology.
- PhD (History) 1974 (Univ. of Calif.)
- BA (Biology) 1969 Westmont College
- PhD program (Molecular Biology) fall semester 1969 (Univ. of Calif.)
- PhD program (Immunology) Jan 1983 through Dec 1983 (Rutgers University)
Dr. Michael died from “bleeding-out” in his head. That is, he died of a hemorrhagic stroke because he had no platelets.
Platelets are the smallest blood cells. They are essential for blood clotting. The usual number is 150,000 to 400,000 per cubic millimeter of blood. Dr. Michael had between 0 and 1000 per cubic millimeter.
ITP (immune-mediated thrombocytopenic purpura) is typically caused by antibodies that form against platelets, causing the antibodies to clear the platelets from the circulation.
During the two weeks between when he noticed the petechiae (pinpoint-sized bruises) and had a platelet count of 0-1, the doctors would have been trying to replace his platelets with transfusions and, in addition, turn off his immune reaction with medications like prednisone. Neither of these worked.
The reaction was so strong that all the infused platelets were likewise cleared by the vaccine-triggered antibodies. In other words, the doctors couldn’t turn off his immune reaction to his platelets.
We need to stop regarding these tragedies as acceptable collateral damage. We need to step back from this giddy exuberance and make a cold, hard, risk assessment about these experimental medical interventions. And we need to recognize that these zero-liability vaccines are risky and that where there is risk, there has to be choice.